|
Market Closed -
NYSE
16:00:02 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 183.64 USD | -1.32% |
|
-2.92% | +61.64% |
| 10-20 | Dialysis Providers Under Pressure - U.S. Kidney Care Plan | DP |
| 10-15 | Davita Brings New Clinical Research to Asn Kidney Week, Advancing Evidence for the Next Era of Kidney Care | CI |
| Market Cap | 11.87B 10.6B 9.78B 8.88B 16.62B 1,127B 16.87B 118B 46.59B 590B 44.53B 43.59B 1,861B | P/E 2026 * |
12.6x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 22.69B 20.26B 18.7B 16.97B 31.77B 2,154B 32.26B 225B 89.09B 1,128B 85.14B 83.34B 3,558B | EV / Sales 2026 * |
1.6x | EV / Sales 2027 * | 1.55x |
| Free-Float |
49.06% | Yield 2026 * |
0.91% | Yield 2027 * | 0.91% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DVA | Delayed | |
CBOE
| DVA | Real-time | |
|
London S.E.
| 0I7E | Delayed | |
|
Tradegate
| TRL | Real-time | |
|
Mexican S.E.
| DVA * | End-of-day quote | |
|
Deutsche Boerse AG
| TRL | Delayed | |
|
Börse Stuttgart
| TRL | Delayed | |
|
Boerse Muenchen
| TRL | Real-time | |
|
Berne S.E.
| TRL | End-of-day quote | |
|
Borsa Italiana
| 1DVA | End-of-day quote | |
|
Xetra
| TRL | Delayed |
Last Transcript: DaVita Inc.
| 1 day | -1.32% | ||
| 1 week | -2.92% | ||
| Current month | +4.99% | ||
| 1 month | -0.04% | ||
| 3 months | -20.87% | ||
| 6 months | +20.48% | ||
| Current year | +61.64% |
| 1 week | 171.09 |  | 191.2 |
| 1 month | 171.09 | | 191.2 |
| Current year | 101 | | 247.49 |
| 1 year | 101 | | 247.49 |
| 3 years | 75.47 | | 247.49 |
| 5 years | 65.28 | | 247.49 |
| 10 years | 43.4 | | 247.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 65 | 2019-05-31 |
Joel Ackerman
DFI | Director of Finance/CFO | 61 | 2017-02-26 |
David Maughan
COO | Chief Operating Officer | 49 | 2024-09-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 72 | 2020-05-31 |
Barbara Desoer
BRD | Director/Board Member | 73 | 2015-10-07 |
Javier Rodriguez
BRD | Director/Board Member | 65 | 2019-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/22/26 | Tax | Chief Operating Officer | -7,501 | 0.0118% | ||
| 8/15/26 | Free | Director | 278 | 0.0004% | ||
| 8/15/26 | Free | Chairman | 278 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -2.92% | +42.27% | +136.89% | 11.87B | |
| -1.07% | +0.96% | +13.97% | +35.37% | 121B | |
| +0.37% | +0.11% | +6.31% | +94.51% | 101B | |
| +0.64% | -0.21% | +114.84% | +891.05% | 59.59B | |
| +0.21% | +2.61% | -6.79% | +78.43% | 28.59B | |
| -0.57% | +1.15% | +33.52% | +95.50% | 26.85B | |
| -0.30% | +1.19% | +16.30% | +64.59% | 26.76B | |
| -0.81% | -2.43% | +30.87% | +391.94% | 21.79B | |
| -2.46% | -5.71% | -23.11% | -7.94% | 19.57B | |
| -0.68% | +2.05% | +3.85% | +87.12% | 19.03B | |
| Average | -0.60% | +0.13% | +23.20% | +186.75% | 43.61B | |
| Weighted average by Cap. | -0.38% | +0.55% | +25.47% | +195.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.16B 12.64B 11.67B 10.59B 19.82B 1,344B 20.13B 140B 55.59B 703B 53.12B 52B 2,220B | 14.64B 13.07B 12.06B 10.95B 20.5B 1,390B 20.81B 145B 57.47B 727B 54.92B 53.76B 2,296B |
| Net income | 940M 839M 774M 703M 1.32B 89.21B 1.34B 9.33B 3.69B 46.7B 3.53B 3.45B 147B | 1.01B 901M 832M 755M 1.41B 95.83B 1.44B 10.02B 3.96B 50.16B 3.79B 3.71B 158B |
| Net Debt | 10.82B 9.66B 8.92B 8.09B 15.16B 1,027B 15.39B 107B 42.49B 538B 40.61B 39.75B 1,697B | 10.8B 9.64B 8.9B 8.08B 15.12B 1,025B 15.36B 107B 42.41B 537B 40.53B 39.67B 1,694B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | US$183.64 | -1.32% | 618,031 |
| 26-10-22 | US$186.10 | +5.25% | 931,346 |
| 26-10-21 | US$176.81 | +0.83% | 1,140,395 |
| 26-10-20 | US$175.35 | -6.23% | 2,071,606 |
| 26-10-19 | US$187.00 | -0.17% | 325,523 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DVA Stock
Select your edition
All financial news and data tailored to specific country editions
